Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia.
Kantarjian HM, O'Brien S, Cortes JE, Giralt SA, Rios MB, Shan J, Giles FJ, Thomas DA, Faderl S, De Lima M, Garcia-Manero G, Champlin R, Arlinghaus R, Talpaz M.
Kantarjian HM, et al. Among authors: de lima m.
Blood. 2002 Sep 1;100(5):1590-5.
Blood. 2002.
PMID: 12176876
Free article.
Clinical Trial.